Bibliographic Details
| Title: |
[Management strategy on hypertension induced by anti-cancer therapy with vascular endothelial growth factor inhibitor]. |
| Authors: |
Yang XL; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116000, China., Guan B; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116000, China., Lyu HC; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116000, China., Jiang YN; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116000, China., Xia YL; Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian 116000, China. |
| Source: |
Zhonghua xin xue guan bing za zhi [Zhonghua Xin Xue Guan Bing Za Zhi] 2021 Oct 24; Vol. 49 (10), pp. 957-962. |
| Publication Type: |
Journal Article |
| Language: |
Chinese |
| Journal Info: |
Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7910682 Publication Model: Print Cited Medium: Print ISSN: 0253-3758 (Print) Linking ISSN: 02533758 NLM ISO Abbreviation: Zhonghua Xin Xue Guan Bing Za Zhi Subsets: MEDLINE |
| Imprint Name(s): |
Original Publication: Beijing, Zhonghua yi xue hui [1973?]- |
| MeSH Terms: |
Hypertension*/chemically induced , Hypertension*/drug therapy , Vascular Endothelial Growth Factor A*, Endothelium, Vascular ; Humans |
| Contributed Indexing: |
Local Abstract: [Publisher, Chinese] 癌症是威胁中国乃至全世界人民健康的疾病。随着抗癌药物的创新研发，癌症患者的生存率已明显提高，但其诱导的心血管并发症也愈发突显。抗癌的明星药物——血管内皮生长因子抑制剂常诱发高血压，并引发严重心血管并发症，影响癌症患者的生存率。然而，现有临床指南对此类高血压的阐述甚少。该文系统地回顾了血管内皮生长因子抑制剂相关高血压的文献并结合我们的临床经验，提出了管理此类高血压患者的意见和建议，供临床医师参考。. |
| Substance Nomenclature: |
0 (Vascular Endothelial Growth Factor A) |
| Entry Date(s): |
Date Created: 20211021 Date Completed: 20211025 Latest Revision: 20211025 |
| Update Code: |
20221216 |
| DOI: |
10.3760/cma.j.cn112148-20210824-00727 |
| PMID: |
34674433 |
| Database: |
MEDLINE |